TG
SRNE

TCW Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

TCW Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-67,147
Closed -$295K – 359
2018
Q3 		$295K Buy
+67,147
New +$295K ﹤0.01% 316